← MOLINA HEALTHCARE, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $52.0m
($512.0m) -1084.62%
$707.0m +238.09%
$737.0m +4.24%
$673.0m -8.68%
$659.0m -2.08%
$792.0m +20.18%
$1.1b +37.75%
$1.2b +8.07%
$472.0m -59.97%
—
Amortization of Intangible Assets $32.0m $31.0m $21.0m $18.0m $15.0m $49.0m $77.0m $85.0m $82.0m $91.0m —
Depreciation $45.0m $42.0m $36.0m $21.0m $16.0m $16.0m $17.0m $10.0m $16.0m $7.0m $7.0m
Depreciation, Depletion and Amortization $182.0m $178.0m $127.0m $89.0m $88.0m $131.0m $176.0m $171.0m $186.0m $195.0m $168.0m
Deferred Income Tax Expense (Benefit) $22.0m ($94.0m) ($6.0m) $10.0m ($19.0m) ($24.0m) ($66.0m) ($31.0m) $53.0m $43.0m ($20.0m)
Share-based Payment Arrangement, Expense $26.0m $46.0m $27.0m $39.0m $57.0m $72.0m $103.0m $115.0m $116.0m $47.0m $76.0m
Share-based Payment Arrangement, Noncash Expense $26.0m $46.0m $27.0m $39.0m $57.0m $72.0m $103.0m $115.0m $116.0m $47.0m $76.0m
Share-based compensation $26.0m $46.0m $27.0m $39.0m $57.0m $72.0m $103.0m $115.0m $116.0m $47.0m $76.0m
Goodwill and Intangible Asset Impairment — $470.0m $0 $0 — — — — — — —
Goodwill, Impairment Loss $0 $434.0m $0 $0 — $0 — — — — $0
Impairment of Intangible Assets, Finite-lived — — $0 — — — — — — — —
Nonoperating Income (Expense) ($101.0m) ($57.0m) ($132.0m) ($72.0m) ($117.0m) ($145.0m) ($110.0m) ($109.0m) — — —
Other Nonoperating Income (Expense) $0 $61.0m ($17.0m) $15.0m ($15.0m) ($25.0m) $0 $0 — — —
Receivables ($348.0m) $103.0m ($530.0m) ($76.0m) ($100.0m) ($415.0m) ($95.0m) ($778.0m) ($78.0m) ($145.0m) $369.0m
Accounts payable, accrued liabilities and other ($4.0m) ($12.0m) $45.0m $2.0m $78.0m $138.0m $55.0m $328.0m $115.0m ($221.0m) $146.0m
Deferred revenue $92.0m ($34.0m) ($21.0m) $38.0m $126.0m ($5.0m) ($11.0m) $59.0m ($367.0m) ($51.0m) —
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims $14.8b $17.1b $15.1b $13.9b $15.8b $23.7b $27.2b $28.7b $34.4b $39.5b —
Medical claims and benefits payable $226.0m $263.0m ($226.0m) ($107.0m) $544.0m $471.0m $153.0m $580.0m ($40.0m) ($132.0m) —
Prepaid expenses and other current assets ($69.0m) ($56.0m) $6.0m $28.0m ($16.0m) ($19.0m) ($124.0m) ($69.0m) ($57.0m) $52.0m —
Net Cash Provided by (Used in) Operating Activities $673.0m
$804.0m +19.47%
($314.0m) -139.05%
$427.0m +235.99%
$1.9b +342.62%
$2.1b +12.12%
$773.0m -63.52%
$1.7b +115.01%
$644.0m -61.25%
($535.0m) -183.07%
$365.0m +168.22%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $176.0m $86.0m $30.0m $57.0m $74.0m $77.0m $91.0m $84.0m $100.0m $101.0m ($94.0m)
Proceeds from sales and maturities of investments $2.0b $1.8b $2.4b $2.3b $1.1b $1.3b $1.4b $772.0m $1.1b $1.4b —
Purchases of investments ($1.9b) ($2.7b) ($1.4b) ($2.5b) ($670.0m) ($2.7b) ($1.9b) ($1.4b) ($1.1b) ($751.0m) —
Payments to Acquire Businesses, Net of Cash Acquired $48.0m $0 $0 — $755.0m $129.0m $134.0m $3.0m $344.0m $245.0m $0
Payments for (Proceeds from) Other Investing Activities $19.0m $28.0m $18.0m $2.0m ($2.0m) $63.0m $50.0m ($4.0m) ($1.0m) ($1.0m) —
Net Cash Provided by (Used in) Investing Activities ($202.0m) ($1.1b) $1.1b ($293.0m) ($400.0m) ($1.7b) ($790.0m) ($744.0m) ($464.0m) $312.0m $288.0m
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt — ($14.0m) ($22.0m) $15.0m ($15.0m) ($25.0m) — — — — —
Proceeds from Issuance of Long-term Debt $0 — — — — — — — — — $1.3b
Proceeds from borrowings under credit facility and term loans $0 $300.0m $0 $220.0m — — — $0 $300.0m $1.1b —
Common stock purchases — $0 $0 ($47.0m) ($606.0m) ($128.0m) ($400.0m) $0 ($1.0b) ($1.0b) —
Common stock withheld to settle employee tax obligations — — — ($7.0m) ($8.0m) ($53.0m) ($54.0m) ($60.0m) ($57.0m) ($37.0m) —
Payments for Repurchase of Common Stock — — — $47.0m $606.0m $128.0m $400.0m $0 $1.0b $1.0b —
Proceeds from Issuance of Common Stock $0 $0 — — — — — — — — —
Proceeds from (Payments for) Other Financing Activities $1.0m ($1.0m) $18.0m $29.0m $2.0m $1.0m $33.0m $2.0m ($30.0m) $29.0m —
Net Cash Provided by (Used in) Financing Activities $19.0m
$636.0m +3247.37%
($1.2b) -287.58%
($552.0m) +53.73%
$225.0m +140.76%
($183.0m) -181.33%
($441.0m) -140.98%
($58.0m) +86.85%
($347.0m) -498.28%
($170.0m) +51.01%
($152.0m) +10.59%
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents $486.0m $378.0m ($364.0m) ($418.0m) $1.7b $283.0m ($458.0m) $860.0m ($167.0m) ($393.0m) —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $486.0m $378.0m ($364.0m) ($418.0m) $1.7b $283.0m ($458.0m) $860.0m ($167.0m) ($393.0m) $5.1b
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period $2.9b $3.3b $2.9b $2.5b $4.2b $4.5b $4.0b $4.9b $4.7b $4.3b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $486.0m $378.0m $2.9b $2.5b $4.2b $4.5b $4.0b $4.9b $4.7b $4.3b $5.1b
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Amounts due government agencies $473.0m $341.0m ($574.0m) ($303.0m) $446.0m $1.0b ($428.0m) $196.0m ($453.0m) ($591.0m) —
Derivative, Gain (Loss) on Derivative, Net $0 $0 $0 $0 $0 — — — — — —
Gain (Loss) on Disposition of Business — — ($15.0m) $0 $0 — — — — — —
General and Administrative Expense $1.4b $1.6b $1.3b $1.3b $1.5b $2.1b $2.3b $2.5b $2.7b $3.0b —
Goodwill $620.0m $186.0m $143.0m $143.0m — $982.0m $1.1b $1.2b $1.7b $2.0b $0
Income Tax Expense (Benefit) $153.0m ($100.0m) $292.0m $235.0m $288.0m $216.0m $271.0m $373.0m $410.0m $117.0m —
Income Taxes Paid, Net $153.0m $7.0m $240.0m $239.0m $321.0m $235.0m $340.0m $405.0m $379.0m $275.0m —
Income taxes $153.0m $7.0m $240.0m $239.0m $321.0m $235.0m $340.0m ($2.0m) ($18.0m) ($201.0m) —
Insurance Services Revenue — — $407.0m $0 — — — — — — —
Interest Expense Nonoperating — — — — — — — — $118.0m $192.0m —
Interest Paid, Excluding Capitalized Interest, Operating Activities $66.0m $78.0m $93.0m $78.0m $112.0m $127.0m $108.0m $108.0m $121.0m $181.0m —
Net cash paid in business combinations ($48.0m) $0 $0 $0 ($755.0m) ($129.0m) ($134.0m) ($3.0m) ($344.0m) ($245.0m) —
Other, net $1.0m ($1.0m) $18.0m $29.0m $2.0m $1.0m $33.0m $2.0m ($30.0m) $29.0m —
Payments for Repurchase of Warrants — — $549.0m $514.0m $30.0m $0 $0 — — — —
Payments of Financing Costs — $7.0m — — — — — — — — —
Proceeds from senior notes offerings, net of issuance costs $0 $325.0m $0 $0 $1.4b $740.0m $0 $0 $740.0m $838.0m —
Repayment of credit facility and term loans — — $0 $0 ($600.0m) $0 $0 $0 ($300.0m) ($1.1b) —
Restructuring Costs — $234.0m $46.0m $6.0m — — — — — — —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.